According to two studies and a survey, doctors and patients are not participating in a process called shared decision-making regarding the prostate-specific antigen (PSA) test. Shared decision-making is the process by which doctors and patients have a discussion about the advantages and disadvantages of the PSA test and the patient shares his concerns and health issues. The doctor then reviews the options with the patient and together they would decide on personalized options regarding prostate health. This process is beneficial because it informs the patient of the options open to him, and the pros and cons of PSA testing.
Read the full NPR article here.